Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Unicycive Therapeutics, Inc. (UNCY) had Return on Tangible Equity of -39.24% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-6.45M |
|
-- |
|
-- |
|
$6.96M |
|
$-6.96M |
|
$0.52M |
|
$-6.45M |
|
$-6.45M |
|
$-6.45M |
|
$-6.45M |
|
$-6.45M |
|
$-6.45M |
|
$-6.96M |
|
$-6.83M |
|
12.30M |
|
12.30M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$29.53M |
|
$0.08M |
|
$0.47M |
|
$30.00M |
|
$13.57M |
|
-- |
|
-- |
|
$13.57M |
|
$16.43M |
|
$16.43M |
|
$16.43M |
|
14.11M |
|
| Cash Flow Statement Financials | |
$-17.32M |
|
$-0.02M |
|
$13.53M |
|
$26.14M |
|
$22.33M |
|
$-3.81M |
|
$1.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.24% |
|
|
Return on Tangible Equity |
-39.24% |
-21.49% |
|
-39.24% |
|
$1.16 |
|
$-1.41 |
|
$-1.41 |
|